# OnCo record marginal-zone-lymphoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/marginal-zone-lymphoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "marginal-zone-lymphoma" ;
  schema:name "Marginal zone lymphoma"@en ;
  schema:alternateName "MZL"@en, "MALT lymphoma"@en, "Extranodal marginal zone lymphoma"@en, "Splenic marginal zone lymphoma"@en, "Nodal marginal zone lymphoma"@en ;
  schema:description "Marginal zone lymphoma is a slow B-cell lymphoma that often grows where the body has been fighting a chronic infection: the stomach with Helicobacter pylori, the eye, the skin or the spleen. Curing the infection cures many early cases; the rest are treated with rituximab, chemotherapy or BTK inhibitors."@en ;
  schema:url <https://onco.cc/cancers/marginal-zone-lymphoma/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Marginal_zone_B-cell_lymphoma> ;
  schema:citation <https://en.wikipedia.org/wiki/Marginal_zone_B-cell_lymphoma> ;
  onco:tag "subtype-page" ;
  onco:related <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/waldenstrom/>, <https://onco.cc/cancers/mantle-cell-lymphoma/>, <https://onco.cc/cancers/dlbcl/> ;
  onco:terms <https://onco.cc/terms/myd88-l265p/>, <https://onco.cc/terms/ss18-ssx-fusion/> ;
  onco:trials <https://onco.cc/trials/augment/>, <https://onco.cc/trials/zuma-5/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-wotherspoon-h-pylori-malt-lancet-1993/>, <https://onco.cc/key-papers/paper-esmo-marginal-zone-lymphoma-zucca-ann-oncol-2020/>, <https://onco.cc/key-papers/paper-magnolia-zanubrutinib-mzl-ccr-2021/>, <https://onco.cc/key-papers/paper-augment-lenalidomide-rituximab-leonard-jco-2019/> ;
  onco:pipeline <https://onco.cc/drugs/zanubrutinib/>, <https://onco.cc/drugs/lenalidomide/> ;
  onco:standardOfCare <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/hypofractionated-radiotherapy/>, <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/bendamustine/>, <https://onco.cc/drugs/chlorambucil/>, <https://onco.cc/drugs/lenalidomide/>, <https://onco.cc/drugs/zanubrutinib/>, <https://onco.cc/drugs/ibrutinib/> .